Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-21-000093
Filing Date
2021-03-29
Accepted
2021-03-29 12:24:00
Documents
37
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0324form10k.htm 10-K 229524
2 EXHIBIT 31.1 skin0324form10kexh31_1.htm EX-31.1 8146
3 EXHIBIT 31.2 skin0324form10kexh31_2.htm EX-31.2 8160
4 EXHIBIT 32.1 skin0324form10kexh32_1.htm EX-32.1 4173
  Complete submission text file 0001554795-21-000093.txt   1021182

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20201231.xml EX-101.INS 82969
6 XBRL SCHEMA FILE skin-20201231.xsd EX-101.SCH 13053
7 XBRL CALCULATION FILE skin-20201231_cal.xml EX-101.CAL 22843
8 XBRL DEFINITION FILE skin-20201231_def.xml EX-101.DEF 14021
9 XBRL LABEL FILE skin-20201231_lab.xml EX-101.LAB 92428
10 XBRL PRESENTATION FILE skin-20201231_pre.xml EX-101.PRE 71443
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 21780384
SIC: 6770 Blank Checks